D.Western Therapeutics Institute ( ($JP:4576) ) has provided an announcement. D. Western Therapeutics Institute has announced the completion of ...
"Corneal blindness is one of the leading causes of vision loss, affecting about 10 million people worldwide each year," says ...
Wichita Falls parents creating accessibility for son with muscular dystrophy White House tells Supreme Court it doesn’t care about the tariff money raised Kelly Clarkson Looks Incredible (and So ...
Obtained ex-US Regulatory Clearance for DT-818, a Potentially Best-in-Disease Treatment for Myotonic Dystrophy Type-1 (DM1) Trials of DT-216P2 in Friedreich Ataxia (FA) and DT-168 in Fuchs Endothelial ...
Obtained ex-US Regulatory Clearance for DT-818, a Potentially Best-in-Disease Treatment for Myotonic Dystrophy Type-1 (DM1) Trials of DT-216P2 in Friedreich Ataxia (FA) and DT-168 in Fuchs Endothelial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback